Company Information

As of 8/3/2022
Country
China
Headquarters
Hong Kong, China
Industry
Pharmaceuticals
CEO
Wang Xiangming
Company Type
Private
Ticker
-
Revenues ($M)
$119,601
Profits ($M)
$4,544
Market Value ($M)
-
Employees
362,706
Government owned 50% or more.

Key Financials (Last Fiscal Year)
As of 8/3/2022

($ Millions)
% change
Revenues ($M)
$119,601.2
20.3%
Profits ($M)
$4,544
4.9%
Assets ($M)
$318,179.7
-
Total Stockholder Equity ($M)
$45,138.5
-

Profit Ratios
As of 8/3/2022

Profit as % of Revenues
3.8%
Profits as % of Assets
1.4%
Profits as % of Stockholder Equity
10.1%

China Resources Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$99,4384.9%$4,33021.2%$275,692$40,128
2020$94,7583%$3,5722.8%$232,277$32,981
2019$91,98611.9%$3,47510.2%$209,652$28,199
2017$75,776-1%$2,5803.7%$158,291$23,605
2016$76,5742.3%$2,4891.6%$153,154$23,812
SHOW MORE
FortuneFortuneAnalytics tout
Lists ranking China Resources
RANK70
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE